A pharmaceutical composition comprising a GHRH molecule or a pharmaceuticallyacceptablesalt thereof is described, as well as uses thereof and a kit for preparingsuch a pharmaceuticalcomposition. In an embodiment, GHRH molecule or pharmaceutically acceptablesalt thereof istrans-3-hexenoyl-GHRH(1-44)-NH2 or a pharmaceutically acceptable salt thereof.In anembodiment, a pharmaceutical composition comprising about 1.3 to about 1.5 mgof a GHRHmolecule such as trans-3-hexenoyl-GHRH(1-44)-NH2 at a concentration of about3.5 mg/mL ormore, as well as uses thereof and a kit for preparing such a pharmaceuticalcomposition, aredescribed. Uses of such a pharmaceutical composition to obtain plasmaticlevels of e.g.,trans-3-hexenoyl-GHRH(1-44)-NH2 that are bioequivalent to administration of 2mg oftrans-3-hexenoyl-GHRH(1-44)-NH2 at a concentration of 1 mg/mL in a subject arealso described.
